Journals / Dicle Tıp Dergisi / 2017 / Cilt: 44 Sayı: 3

Son Bir Yıl İçindeki Nekrotizan Fasiitis Tanısı Alan Hastaların Değerlendirilmesi

Pages
271–276
Publication Date
2017-09-20
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

E r k e n t a n ı k o n u la n , t e d a vi i ç i n h ız l ı ve a g re s if d eb r itman u y gu la n a n h as t ala r da y ü z gü l dürü c ü s o n u çla r e l d e e di le b i l m e k t e d i r .

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Normal 0 21 false false false TR X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Normal Tablo"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif"; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} A m aç : K l i n iğ i mize b aş v u r a n ne kr otiz a n f as iit i s h as t ala r ı n ın t an ı, t ak ip v e t e d a vi s i i l e i l gi l i d en e yim le r i p a y laş m ak .
📊
Key Findings & Data:Y ö n t e m l er : 01.0 1 .2016 ve 0 1.01.2017 t a r ih l er i a r as ı n da kl i n iği m ize b aş v u r a n ne kr o tiz a n f as iit i s t a n ısı ala n h as t ala r ın ka yıt la r ı i n c e le n di.
💡
Conclusion & Impact:E r k e n t a n ı k o n u la n , t e d a vi i ç i n h ız l ı ve a g re s if d eb r itman u y gu la n a n h as t ala r da y ü z gü l dürü c ü s o n u çla r e l d e e di le b i l m e k t e d i r .
🔬Design:Araştırma Makalesi
📍Scope:2016 Verileri
⚙️Variables:Fournier gangreni · nekrotizan fasiitis · debritman

Özet

Normal 0 21 false false false TR X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Normal Tablo"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif"; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} A m aç : K l i n iğ i mize b aş v u r a n ne kr otiz a n f as iit i s h as t ala r ı n ın t an ı, t ak ip v e t e d a vi s i i l e i l gi l i d en e yim le r i p a y laş m ak . Y ö n t e m l er : 01.0 1 .2016 ve 0 1.01.2017 t a r ih l er i a r as ı n da kl i n iği m ize b aş v u r a n ne kr o tiz a n f as iit i s t a n ısı ala n h as t ala r ın ka yıt la r ı i n c e le n di. H as t ala r ı n y aş , c i n s iy e t, e k h as t al ı k , to p la m a m e l iy a t sa yı s ı, h as t a ne d e y a tış g ü n sa yı s ı ve t e d a viye y a n ıt la r ı i n c e le n di. Bu l gu la r : N e k r otiz a n f as iitis t a n ısı ala n t o p la m 13 h as t a kl i n iğim i z d e t ak ip v e t e d a vi o l du. H as t ala r ın % 62 ’ s i e r k e k ( n :8 ) , %3 8 ’ i ka dın ( n :5) c i n s i y e t idi. H as t ala r ın o r t ala ma y aş ı 61 y a ş ( 38 - 80 y aş ) o lara k b u l undu. H as t ala r ın %6 9 ’ unda ( n :9) diy ab e t e s m e ll itus t an ı s ı v a r i k en , 2 ka d ın h as t a n ın ov e r ka r s i n omu n e d en i i l e b ir yıl ö n c e a m e l iy a t g e ç i r d i kl er i ve s o nr as ı n da k e m o - r a dyo t er a pi al dı kla r ı b e l i r le n di. D iğ e r 2 h as t a n ı n a n a m n e z l e r i n d e g e ç i r i l miş p er i a n a l a p s e ve fistül hi kâ y e s i o l duğu gö r ü l d ü. H as t ala r ın tüm ü n d e ne kr otiz a n f ass iit i n b aşla n gıç b ö l g e s i p e r i a n a l b ö l g e i d i. H as t ala r ın t a n ı al dı k t a n s o nr a d e b r it m a n i ç in o r t ala ma 3 k e z a m el iy a ta al ı n dığı ( mi n :2, m a x : 6 ) , d e b r i t m a n ı s o n r as ı h as t ala r ın %69’u n a ( n : 9) n e g a tif b as ı n çl ı ka p a ma yön t e mi u y gu l a n dığı, %31   h as t a ya ise (n :4) f l e p i l e   ka p a ma u y gu la n dığı gö r ü l dü. Tüm h as t ala r d a n d e b r itm a n e s n as ı n da do k u k ü l türü al ı n dı ve n e kr otiz a n f as iit i s k ü l tür s o n u c u i l e d oğ r u la n dı. H as t ala r ın %77’s i n d e ( n : 10 ) a n ti b iyo t er a pi o la r a k s e f t r i aks o n + m e t r an id a zol k o m b i n as yonu y e t er l i g e l miş i ke n g e r i kala n h as t a l a r da imi pe n e m g r ubu a n t i b iy o tik d e s t e ği g e re kl i o l mu ş t u r . O r t ala ma h as t a ne d e y a tış gün sa yı s ı n ı n 2 4 gün o l duğu ( m i n :4, m a x:71) g ö r ü l dü. H as t ala r ın %9 2 ’ s i ( n :12) b aşa r ı l ı b ir ş e k i l de ş ifa i l e t a b u r c u e di l i r ke n o v er Ca z e m i n i n d e g e l i ş e n n e k r otiz a n f assi tis l i b ir o l gu p o s t o p e ra tif 34. gün ü n d e se psis n e d e n iy l e ka y b e di l di. So n u ç : N e k r otiz a n f as iit i s erk e n t an ı k o n u la r a k t e d a vi e di l m e d i ği n d e s ı kl ı kl a mo r t al ite i l e s e y r e d e b i le n b ir h as t a l ı k tı r . H as t ala r ın b i r ç o ğu i m mün s üp re s i f h as ta o l up t a n ı i ç in g e c i k m e l e r y aşa n ab i l i r . E r k e n t a n ı k o n u la n , t e d a vi i ç i n h ız l ı ve a g re s if d eb r itman u y gu la n a n h as t ala r da y ü z gü l dürü c ü s o n u çla r e l d e e di le b i l m e k t e d i r .

🔖

Cite This Article

Şahiner, İ. T., Kendirci, M., Dolapçı, M. (2017). Son Bir Yıl İçindeki Nekrotizan Fasiitis Tanısı Alan Hastaların Değerlendirilmesi. Dicle Tıp Dergisi, Cilt: 44 Sayı: 3, 271–276. https://doi.org/10.5798/dicletip.339011

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. Norton KS, Johnson LW, Perry T, et al. Management of Fournier's gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Surg. 2002; 68: 709-13.
  2. Singh A, Ahmed K, Aydin A, et al. Fournier's gangrene. A clinical review. ArchItal Urol Androl. 2016;88: 157-64.
  3. Park SJ, Kim DH, Choi CI, et al. Necrotizing soft tissue infection: analysis of the factors related to mortality in 30 cases of a single institution for 5 years. Ann SurgTreat Res. 2016;91: 45-50.
  4. Misiakos EP, Bagias G, Papadopoulos I, et al. Early Diagnosis and Surgical Treatment for Necrotizing Fasciitis: A Multicenter Study. Front Surg. 2017;4:5.
  5. Oymaci E, Coskun A, Yakan S, et al. Evaluation of factors affecting mortality in Fournier's Gangrene: Retrospective clinical study of sixteen cases. Ulus Cerrahi Derg. 2014;30:85-9.
  6. Yadav SK, Jha CK, Bichoo RA. Fournier's Gangrene. J Am Coll Surg. 2017;224:999-1000.
  7. Osbun N, Hampson LA, Holt SK, et al. Low-Volume vs High-Volume Centers and Management of ournier'sGangrene in Washington State. J Am Coll Surg. 2017; 224:270-5 e1.
  8. Sarkut P, Isik O, Ozturk E, et al. Gender does not affect the prognosis of Fournier's gangrene: a case-matched study. Ulus Travma Acil Cerrahi Derg. 2016;22:541-4.
  9. Sehmi S, Osaghae S. Type II diabetesmellitus: new presentation manifesting as Fournier's gangrene. JRSM Short Rep. 2011;2:51.
  10. Garcia Marin A, Turegano Fuentes F, Cuadrado Ayuso M, et al. Predictive factors for mortality in Fournier' gangrene: a series of 59 cases. Cir Esp. 2015;93:12-7.
  11. Prokop A, Gawenda M, Witt J, Schmitz-Rixen T. [Fournier gangrene]. Langenbecks Arch Chir. 1994;379: 224-8.
  12. Bocchiotti MA, Bogetti P, Parisi A, et al. Management of Fournier's gangrenenon-healing wounds by autologous skin micrograft biotechnology: a new technique. J Wound Care. 2017; 26:314-7.
  13. Dorp MV, Roovers E, Tondu T, Thiessen F. Simplified Penoscrotal Reconstruction for Extensive Fournier Gangrene Defects. Urol J. 2016;13:2927-9.
  14. Ozkan OF, Koksal N, Altinli E, et al. Fournier's gangrene current approaches. IntWound J. 2016;13:713-6.
  15. Izadi D, Coelho J, Gurjal S, Salim F. Fournier's Gangrene and the Reconstructive Challenges for the Plastic Surgeon. Eplasty. 2016;16:ic38.
  16. Wallner C, Behr B, Ring A, et al. [Reconstructive methods after Fournier gangrene]. Urologe A. 2016; 55:484-8.
  17. Jaworski R, Irga-Jaworska N, Naumiuk L, et al. Fournier Gangrene Caused by Candida albicans in an Infant After Cardiac Surgery. Mycopathologia. 2017;182:409-12. 18. Chalya PL, Igenge JZ, Mabula JB, Simbila S. Fournier's gangrene at a tertiary health facility in North western Tanzania: a single centre experiences with 84 patients. BMC Res Notes. 2015;8:481.
  18. Taviloglu K, Cabioglu N, Cagatay A, et al. Idiopath icnecrotizing fasciitis: risk factors and strategies for management. Am Surg. 2005;71:315-20.
  19. Lauerman M, Kolesnik O, Sethuraman K, et al. Less is More? Antibiotic duration and outcomes in fournier's gangrene. J Trauma Acute Care Surg. 2017.
  20. Furr J, Watts T, Street R, et al. Contemporary Trends in the Inpatient Management of Fournier's Gangrene: Predictors of Length of Stay and Mortality Based on Population-based Sample. Urology. 2017;102:79-84.
  21. Czymek R, Kujath P, Bruch HP, et al. Treatment, outcome and quality of life after Fournier's gangrene: a multicentre study. Colorectal Dis. 2013;15:1529-36.
  22. Sorensen MD, Krieger JN, Rivara FP, et al. Fournier'sgangrene: management and mortality predictors in a population based study. J Urol.2009;182:2742-7.
  23. Yilmazlar T, Isik O, Ozturk E, et al. Fournier's gangrene: review of 120 patients and predictors of mortality. Ulus Travma Acil Cerrahi Derg. 2014;20:333-7.
  24. Dorp MV, Roovers E, Tondu T, Thiessen F. Simplified Penoscrotal Reconstruction for Extensive Fournier Gangrene Defects. Urol J. 2016;13:2927-9.